Sandra Muñoz-Galván
Impact in
- Geriatrics and Gerontology top 5%
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
- Oncology 21
- Cancer Cells and Metastasis 5
- Peptidase Inhibition and Analysis 5
- PARP inhibition in cancer therapy 5
- Cancer-related Molecular Pathways 3
-
- DNA Repair Mechanisms 7
- Cancer-related gene regulation 3
- Co-authors
- Amancio Carnero (31 shared papers)Manuel P. Jiménez-García (5 shared papers)Marco Pérez (10 shared papers)Andrés Aguilera (5 shared papers)Daniel Otero-Albiol (7 shared papers)Antonio Lucena-Cacace (4 shared papers)Eva M. Verdugo‐Sivianes (11 shared papers)Purificación Estévez-García (6 shared papers)
- Journals
- Oncotarget (4 papers)Oncogene (3 papers)Advanced Healthcare Materials (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Cells (2 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Sandra Muñoz-Galván
40 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Geriatrics and Gerontology 71
- Oncology 362
- Cancer Research 187
- Molecular Biology 621
- Cell Biology 127
Countries citing papers authored by Sandra Muñoz-Galván
This map shows the geographic impact of Sandra Muñoz-Galván's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Muñoz-Galván with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Muñoz-Galván more than expected).
Fields of papers citing papers by Sandra Muñoz-Galván
This network shows the impact of papers produced by Sandra Muñoz-Galván. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Muñoz-Galván. The network helps show where Sandra Muñoz-Galván may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Muñoz-Galván, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 132 | |
| 2 | 2020 | 95 | |
| 3 | 2011 | 85 | |
| 4 | 2013 | 73 | |
| 5 | 2020 | 64 | |
| 6 | 2012 | 56 | |
| 7 | 2015 | 53 | |
| 8 | 2018 | 42 | |
| 9 | 2019 | 36 | |
| 10 | 2012 | 31 | |
| 11 | 2015 | 29 | |
| 12 | 2015 | 28 | |
| 13 | 2013 | 26 | |
| 14 | 2012 | 26 | |
| 15 | 2015 | 25 | |
| 16 | 2013 | 22 | |
| 17 | 2020 | 18 | |
| 18 | 2021 | 17 | |
| 19 | 2020 | 17 | |
| 20 | 2024 | 16 |
About Sandra Muñoz-Galván
Sandra Muñoz-Galván is a scholar working on Oncology, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Cell Biology, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (7 papers), Cancer Cells and Metastasis (5 papers), Peptidase Inhibition and Analysis (5 papers), PARP inhibition in cancer therapy (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Mechanisms and Therapy (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Geriatrics and Gerontology (71 citations), Oncology (362 citations), Cancer Research (187 citations), Molecular Biology (621 citations) and Cell Biology (127 citations). Sandra Muñoz-Galván has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Amancio Carnero, Manuel P. Jiménez-García, Marco Pérez, Andrés Aguilera, Daniel Otero-Albiol, Antonio Lucena-Cacace, Eva M. Verdugo‐Sivianes, Purificación Estévez-García, Blanca Felipe‐Abrio and Sonia Jimeno. Their work appears in journals such as Oncotarget, Oncogene, Advanced Healthcare Materials, Journal of Experimental & Clinical Cancer Research and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.